Search - tctmd.com

Displaying 681 - 700 of 1058

Sort: Relevancy | Date

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Philippines Presents a Case: Cardiogenic Shock in Non-STEMI

Presenter: Rui Campante Teles, Marcelo Jose de Carvalho Cantarelli, Richard Nicandro R Torres

October 30, 2016

Presentation TCT 2016

TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75 Nationwide Registry

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann

October 30, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Maurizio Menichelli

October 30, 2016

Presentation TCT 2016

STEMI Treatment Strategies: Drugs and Devices

Presenter: Tayo A. Addo, Dharam J. Kumbhani

October 30, 2016

Presentation TCT 2016

NSTEACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

ILUMIEN 3: OCT Imaging Matches IVUS but Fails To Beat Angiography for Stent Guidance in PCI

News Conference News TCT 2016

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Shelley Wood

October 30, 2016

Presentation TCT 2016

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Presenter: C. Michael Gibson, Daniel I. Simon, Sunil V. Rao

October 30, 2016

Advertisement

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease

TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry

Philippines Presents a Case: Cardiogenic Shock in Non-STEMI

TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75 Nationwide Registry

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

STEMI Treatment Strategies: Drugs and Devices

NSTEACS: Risk Stratification and Treatment

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content